NOT FOR DISTRIBUTION
Header cover image

Shandong Weigao Group Medical Polymer

Market Cap

HK$68.7b

Last Updated

2021/04/14 10:16 UTC

Data Sources

Company Financials +

Executive Summary

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People’s Republic of China. More Details


Snowflake Analysis

Excellent balance sheet with acceptable track record.


Similar Companies

Share Price & News

How has Shandong Weigao Group Medical Polymer's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1066 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 1066's weekly volatility (7%) has been stable over the past year.


Market Performance


7 Day Return

-1.6%

1066

-0.7%

HK Medical Equipment

-2.5%

HK Market


1 Year Return

36.7%

1066

38.4%

HK Medical Equipment

26.4%

HK Market

Return vs Industry: 1066 underperformed the Hong Kong Medical Equipment industry which returned 48% over the past year.

Return vs Market: 1066 exceeded the Hong Kong Market which returned 29.5% over the past year.


Shareholder returns

1066IndustryMarket
7 Day-1.6%-0.7%-2.5%
30 Day21.4%6.6%-1.8%
90 Day-0.7%-9.3%0.5%
1 Year37.8%36.7%39.8%38.4%31.2%26.4%
3 Year223.1%210.2%198.8%185.6%6.0%-5.2%
5 Yearn/a280.9%248.2%47.3%22.5%

Long-Term Price Volatility Vs. Market

How volatile is Shandong Weigao Group Medical Polymer's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Shandong Weigao Group Medical Polymer undervalued compared to its fair value and its price relative to the market?

28.29x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 1066 (HK$15.16) is trading above our estimate of fair value (HK$12.81)

Significantly Below Fair Value: 1066 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 1066 is good value based on its PE Ratio (28.2x) compared to the HK Medical Equipment industry average (28.5x).

PE vs Market: 1066 is poor value based on its PE Ratio (28.2x) compared to the Hong Kong market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: 1066 is poor value based on its PEG Ratio (1.5x)


Price to Book Ratio

PB vs Industry: 1066 is overvalued based on its PB Ratio (3.3x) compared to the HK Medical Equipment industry average (3.1x).


Future Growth

How is Shandong Weigao Group Medical Polymer forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

18.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1066's forecast earnings growth (18.3% per year) is above the savings rate (1.5%).

Earnings vs Market: 1066's earnings (18.3% per year) are forecast to grow slower than the Hong Kong market (19.7% per year).

High Growth Earnings: 1066's earnings are forecast to grow, but not significantly.

Revenue vs Market: 1066's revenue (16.2% per year) is forecast to grow faster than the Hong Kong market (13.8% per year).

High Growth Revenue: 1066's revenue (16.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1066's Return on Equity is forecast to be low in 3 years time (14.6%).


Past Performance

How has Shandong Weigao Group Medical Polymer performed over the past 5 years?

15.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1066 has high quality earnings.

Growing Profit Margin: 1066's current net profit margins (17.9%) are higher than last year (17.8%).


Past Earnings Growth Analysis

Earnings Trend: 1066's earnings have grown by 15.4% per year over the past 5 years.

Accelerating Growth: 1066's earnings growth over the past year (10%) is below its 5-year average (15.4% per year).

Earnings vs Industry: 1066 earnings growth over the past year (10%) underperformed the Medical Equipment industry 19.7%.


Return on Equity

High ROE: 1066's Return on Equity (11.7%) is considered low.


Financial Health

How is Shandong Weigao Group Medical Polymer's financial position?


Financial Position Analysis

Short Term Liabilities: 1066's short term assets (CN¥14.1B) exceed its short term liabilities (CN¥4.5B).

Long Term Liabilities: 1066's short term assets (CN¥14.1B) exceed its long term liabilities (CN¥4.5B).


Debt to Equity History and Analysis

Debt Level: 1066's debt to equity ratio (23.3%) is considered satisfactory.

Reducing Debt: 1066's debt to equity ratio has increased from 9.4% to 23.3% over the past 5 years.

Debt Coverage: 1066's debt is well covered by operating cash flow (52.3%).

Interest Coverage: 1066's interest payments on its debt are well covered by EBIT (53.2x coverage).


Balance Sheet


Dividend

What is Shandong Weigao Group Medical Polymer current dividend yield, its reliability and sustainability?

1.06%

Current Dividend Yield


Upcoming Dividend Payment

TodayApr 14 2021Ex Dividend DateMay 27 2021Dividend Pay DateJul 05 202139 days from Ex DividendBuy in the next 42 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 1066's dividend (1.07%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (1.97%).

High Dividend: 1066's dividend (1.07%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.01%).


Stability and Growth of Payments

Stable Dividend: 1066's dividend payments have been volatile in the past 10 years.

Growing Dividend: 1066's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (28.7%), 1066's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 1066's dividends in 3 years are forecast to be well covered by earnings (23.2% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average management tenure


CEO

Rinan Cong (39 yo)

0.083

Tenure

Mr. Rinan Cong serves as Chief Executive Officer at Shandong Weigao Group Medical Polymer Company Limited since March 30, 2021. He joined the Company in August 2003. During August 2003 to December 2013, he...


Leadership Team

Experienced Management: 1066's management team is considered experienced (4.2 years average tenure).


Board Members

Experienced Board: 1066's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Shandong Weigao Group Medical Polymer Company Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Shandong Weigao Group Medical Polymer Company Limited
  • Ticker: 1066
  • Exchange: SZSC
  • Founded: 2000
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: HK$68.739b
  • Shares outstanding: 4.52b
  • Website: https://www.weigaogroup.com

Number of Employees


Location

  • Shandong Weigao Group Medical Polymer Company Limited
  • Torch Hi-Tech Science Park
  • 18 Xingshan Road
  • Weihai
  • Shandong Province
  • 264210
  • China

Listings


Biography

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People’s Republic of China. The company operates thr...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/14 10:16
End of Day Share Price2021/04/13 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.